Drug Trial Radar · NCT05279716
Study in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag Isopropyl
Last checked: Nov 20, 2026Latest source record: Mar 15, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
150
Planned (sponsor's estimate)
Start
Feb 15, 2022
Primary completion
Dec 8, 2022
Study completion Nov 20, 2023
Sponsor
- Lead sponsor
- Santen Pharmaceutical Asia Pte. Ltd.Industry
- Sponsor type
- Industry
- First posted
- Mar 15, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years, up to 79 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is for patients have been using prostaglandin analogue eye drops with a preservative for 3 months or more and have been diagnosed with prostaglandin-associated peri-orbital disease. the investigators would like to confirm the real world evidence(RWE) of safety and efficacy after changing to Eybelis ophthalmic solution 0.002%.
Conditions
- Normal Tension Glaucoma
- Primary Open-angle Glaucoma
- Glaucoma, Suspect
- Ocular Hypertension
Interventions
Eybelis ophthalmic solution 0.002%Drug
Ophthalmic eye drop
Primary outcomes
What the sponsor says the trial is designed to measure.
- Improvement rate of DUES(Deepening of Upper Eyelid Sulcus)Time frame: 24 weeks
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Seoul National University Bundang Hospital
Seongnam-si, South Korea · Not yet recruiting
Asan Medical Center
Seoul, South Korea · Recruiting
Kangbuk Samsung Hospital
Seoul, South Korea · Recruiting
Kim's Eye Hospital
Seoul, South Korea · Recruiting
Korea University Anam Hospital
Seoul, South Korea · Recruiting
Seoul National University Hospital
Seoul, South Korea · Recruiting
Seoul ST. Mary's Hospital
Seoul, South Korea · Recruiting
Severance Hospital
Seoul, South Korea · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.